Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
Taiwan · Delayed Price · Currency is TWD 83.10
-1.00 (-1.19%)
At close: Jul 9, 2026
Foresee Pharmaceuticals Market Cap
Foresee Pharmaceuticals has a market cap or net worth of 13.09 billion as of July 9, 2026. Its market cap has increased by 31.08% in one year.
Market Cap
13.09B
Enterprise Value
12.60B
Revenue
401.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
83.10
Market Cap Chart
Since April 12, 2016, Foresee Pharmaceuticals's market cap has increased from 7.35B to 13.09B, an increase of 78.09%. That is a compound annual growth rate of 5.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 13.09B | 3.10% |
| Dec 31, 2025 | 12.70B | 5.86% |
| Dec 31, 2024 | 12.00B | -8.16% |
| Dec 29, 2023 | 13.06B | 20.98% |
| Dec 30, 2022 | 10.80B | -23.14% |
| Dec 30, 2021 | 14.05B | 34.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 29.38B |
| TTY Biopharm Company | 19.20B |
| Handa Pharmaceuticals | 18.15B |
| Synmosa Biopharma | 16.77B |
| ScinoPharm Taiwan | 16.53B |
| YungShin Global Holding | 14.46B |
| Grape King Bio | 13.48B |
| Standard Chemical & Pharmaceutical | 11.37B |